OMNI Pharma held the launch ceremony of the new inhalation preparation industrialization project

NMPA approves shifeichang in patients with reversible airway obstruction

Omni Pharma completed the D round of hundreds of millions RMB financing, led by Shanghai Healthcare Capital

OMNI Pharma announces the merger with Shanghai SMC Biotechnology Co., Ltd. to accelerate the pace of commercialization